These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2988323

  • 21. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ, Leis LA, Francis GS.
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [Abstract] [Full Text] [Related]

  • 22. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K, Karsch KR, Weisenberger H, Tidow S, Faul C, Renn W.
    J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061
    [Abstract] [Full Text] [Related]

  • 23. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS, Wharton KA, White BP, Lumley P.
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [Abstract] [Full Text] [Related]

  • 24. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 25. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS, Rao PS, Greenberg MA, Buttrick PM, Sussman II, Levite HA, Grose RM, Perez-Davila V, Strain JE, Spaet TH.
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [Abstract] [Full Text] [Related]

  • 26. Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.
    Aviram M, Winterstein G, Brook JG.
    Br J Clin Pharmacol; 1985 Jun; 19(6):715-9. PubMed ID: 2992558
    [Abstract] [Full Text] [Related]

  • 27. Effects of heparin on prostacyclin binding and platelet adenylate cyclase activity stimulated by iloprost and forskolin.
    Jaschonek K, Faul C, Daiss W, Weisenberger H.
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):199-206. PubMed ID: 2432618
    [Abstract] [Full Text] [Related]

  • 28. Effect on human platelets of catecholamines at levels achieved in the circulation.
    Ardlie NG, McGuiness JA, Garrett JJ.
    Atherosclerosis; 1985 Dec; 58(1-3):251-9. PubMed ID: 3004519
    [Abstract] [Full Text] [Related]

  • 29. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P, Colli S, Sirtori C, Tremoli E, Paoletti R.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Dec; 13():363-9. PubMed ID: 2408447
    [Abstract] [Full Text] [Related]

  • 30. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G, Silver MJ, de Gaetano G.
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D, de Nucci G, Vane JR.
    Thromb Haemost; 1991 Apr 08; 65(4):421-4. PubMed ID: 1647553
    [Abstract] [Full Text] [Related]

  • 37. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
    Jørgensen KA, Dyerberg J, Stoffersen E.
    Thromb Res; 1980 Sep 15; 19(6):877-81. PubMed ID: 6258262
    [No Abstract] [Full Text] [Related]

  • 38. Interaction of ethanol, prostacyclin, and aspirin in determining human platelet reactivity in vitro.
    Jakubowski JA, Vaillancourt R, Deykin D.
    Arteriosclerosis; 1988 Sep 15; 8(4):436-41. PubMed ID: 2840054
    [Abstract] [Full Text] [Related]

  • 39. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG.
    Adv Prostaglandin Thromboxane Res; 1980 Sep 15; 6():317-20. PubMed ID: 6992529
    [No Abstract] [Full Text] [Related]

  • 40. Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil.
    Weber DR, Nichols WK, Mohammad SF.
    Thromb Res; 1986 May 15; 42(4):477-87. PubMed ID: 3012821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.